MedPath

Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)

Completed
Conditions
Dementia Alzheimers
Cognitive Impairment
Cognition Disorders
Cognitive Abnormality
Cognition Disorders in Old Age
Dementia, Alzheimer Type
Cognitive Change
Cognitive Deterioration
Cognitive Impairment, Mild
Dementia, Mild
Interventions
Diagnostic Test: MoCA
Registration Number
NCT03246269
Lead Sponsor
Andreas Monsch
Brief Summary

This observational cohort study in healthy volunteers establishes normative data for the German version of the Montreal Cognitive Assessment (MoCA) and investigates the possible impacts of demographics on the MoCA total score.

Detailed Description

The Montreal Cognitive Assessment (MoCA) is a short tool to evaluate a multitude of cognitive domains (visuospatial / executive functioning, object naming, memory, attention, language, abstraction, orientation). The original English MoCA consistently showed very high sensitivity and specificity in distinguishing patients with mild cognitive impairment from healthy controls. Therefore it is an excellent tool for early recognition of cognitive disorders. Based on a Canadian sample, the MoCA proposes a cut-off-value of 26/30 points. However, there is increasing evidence of intercultural differences in terms of the best cut-off-score. In addition the original version only slightly corrects for possible influences of education - an adjustment for age- or gender-related effects is missing. Therefore, the aim of our study was to investigate the possible impacts of demographics on the MoCA total score and to provide normative values for a German-speaking population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
334
Inclusion Criteria
  • Age ≥65 years
  • Education ≥7 years
  • Fluency in the German language
  • Written informed consent
Exclusion Criteria
  • History of cognitive impairment
  • Depression
  • Severe sensory or motor impairment interfering with cognitive testing
  • Serious somatic disease
  • Disease or event affecting the central nervous system
  • Cerebrovascular disease
  • Regular medication with psychoactive drugs except for benzodiazepines
  • Participation in a cognitive study within the last 3 months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MoCA cohortMoCAThe German MoCA is administered once to all study participants.
Primary Outcome Measures
NameTimeMethod
Montreal Cognitive Assessment (MoCA) - German versionBaseline

Total score of the MoCA

Secondary Outcome Measures
NameTimeMethod
Mini-Mental State Examination (MMSE)Baseline

Total score of the MMSE

Geriatric Depression Scale (GDS)Baseline

Total score of the GDS

Consortium to Establish a Registry for Alzheimer's Disease - Neuropsychological Assessment Battery (CERAD-NAB)Baseline

Total score of the CERAD-NAB

© Copyright 2025. All Rights Reserved by MedPath